Novo Nordisk Wegovy Pill Launches, Expanding Access to Weight-Loss Drugs
Novo Nordisk has launched a $149 Wegovy pill, marking the first oral GLP-1 medication approved for weight loss in the U.S. According to reports, this once-daily pill provides an alternative to injectable treatments, which have seen significant demand. The development aims to broaden access to weight-loss drugs.
Never miss a Web3 update
Join our Telegram channel to receive news in real-time, straight to your phone.